Shares of Molina Healthcare Inc. (NYSE:MOH) have earned a consensus recommendation of “Hold” from the twelve ratings firms that are currently covering the stock. Two equities research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $59.75.

Several analysts have commented on MOH shares. Jefferies Group restated a “buy” rating and issued a $63.00 price objective (down from $66.00) on shares of Molina Healthcare in a report on Thursday, July 28th. Leerink Swann restated a “buy” rating on shares of Molina Healthcare in a report on Thursday, July 28th. Goldman Sachs Group Inc. upgraded shares of Molina Healthcare from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $51.00 to $58.00 in a report on Monday, September 19th. Zacks Investment Research lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating in a report on Monday, October 3rd. Finally, Cantor Fitzgerald restated a “hold” rating and issued a $55.00 price objective on shares of Molina Healthcare in a report on Friday, July 29th.

In other Molina Healthcare news, Director Dale B. Wolf sold 3,000 shares of Molina Healthcare stock in a transaction that occurred on Monday, November 7th. The shares were sold at an average price of $57.63, for a total value of $172,890.00. Following the completion of the sale, the director now owns 16,071 shares of the company’s stock, valued at approximately $926,171.73. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Garrey Carruthers sold 1,600 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, September 13th. The stock was sold at an average price of $55.46, for a total transaction of $88,736.00. Following the completion of the sale, the director now directly owns 9,508 shares of the company’s stock, valued at approximately $527,313.68. The disclosure for this sale can be found here. Corporate insiders own 6.89% of the company’s stock.

A number of large investors have recently bought and sold shares of MOH. Capital World Investors increased its stake in Molina Healthcare by 25.1% in the second quarter. Capital World Investors now owns 5,431,000 shares of the company’s stock worth $271,007,000 after buying an additional 1,090,370 shares during the period. Redmile Group LLC increased its stake in Molina Healthcare by 156.9% in the second quarter. Redmile Group LLC now owns 845,360 shares of the company’s stock worth $42,183,000 after buying an additional 516,347 shares during the period. Deerfield Management Co. bought a new stake in Molina Healthcare during the second quarter worth approximately $21,756,000. Victory Capital Management Inc. increased its stake in Molina Healthcare by 120.9% in the second quarter. Victory Capital Management Inc. now owns 728,913 shares of the company’s stock worth $36,373,000 after buying an additional 398,897 shares during the period. Finally, Cambiar Investors LLC bought a new stake in Molina Healthcare during the third quarter worth approximately $22,306,000. 89.26% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare (NYSE:MOH) traded up 1.31% during trading on Wednesday, reaching $52.68. The company’s stock had a trading volume of 462,425 shares. Molina Healthcare has a 1-year low of $44.50 and a 1-year high of $67.87. The company’s 50 day moving average price is $55.21 and its 200-day moving average price is $53.51. The stock has a market cap of $2.99 billion, a P/E ratio of 23.04 and a beta of 1.19.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Thursday, October 27th. The company reported $0.85 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.09. The company earned $4.50 billion during the quarter, compared to analyst estimates of $4.37 billion. Molina Healthcare had a net margin of 0.76% and a return on equity of 9.38%. Molina Healthcare’s revenue for the quarter was up 24.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.89 earnings per share. Equities analysts forecast that Molina Healthcare will post $2.79 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2016/11/23/molina-healthcare-inc-moh-given-average-rating-of-hold-by-analysts.html.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other. Its Health Plans segment consists of health plans in approximately 10 states and the Commonwealth of Puerto Rico, and its direct delivery business.

5 Day Chart for NYSE:MOH

Receive News & Stock Ratings for Molina Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc. and related stocks with our FREE daily email newsletter.